La cadena de opciones muestra datos clave de las opciones de acciones de Bullfrog AI Hldgs a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Bullfrog AI Hldgs..

Bullfrog AI Hldgs (NASDAQ:BFRG) Bolsa, Cadena de Opciones

Bullfrog AI Hldgs

Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.

Bullfrog AI Holdings, Inc. - Common Stock

Bullfrog AI Holdings Inc

WIIM

Tempus AI shares are trading higher after the company announced the launch of its FDA-approved xT CDx test for clinicians nationwide.

RBC Capital analyst Gregory Renza reiterates IDEAYA Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) with a Outperform and maintains $61 price target.

News

Price Target

Reiteration

Analyst Ratings

IDYA

RBC Capital Reiterates Outperform on IDEAYA Biosciences, Maintains $61 Price Target

PHIO

Phio Pharmaceuticals shares are trading lower after the company announced a $2.5 million registered direct offering.

U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 600 points on Wednesday.
Following the market opening Wednesday, the Dow traded up 1.43% to 43,130.23 while the NASDAQ rose 1.62% to 19,353.59. The S&amp;P 500 also rose, gaining, 1.33% to 5,920.50.
Check This Out: <a href="https://www.benzinga.com/25/01/42998360/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-delivering-high-dividend-yields-2">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields</a>
Leading and Lagging Sectors Consumer discretionary shares rose by 2.2% on Tuesday.
In trading on Tuesday, health care shares fell by 0.4%.
Top Headline
The headline Consumer Price Index rose 2.9% year-over-year in December, according to Wednesday's data from the Bureau of Labor Statistics. This marks an increase from November&#8217;s 2.7% and matches economist forecasts. Notably, it represents the third straight inflation increase and highest annual rate since July 2024.
On a monthly basis, consumer prices increased 0.4%, up from both the previous month&#8217;s 0.3% gain and the 0.3% predicted by analysts.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>Safe &amp; Green Holdings Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares shot up 176% to $1.4899. Safe &amp; Green Holdings announced the execution of a binding Letter of Intent to acquire 100% of the outstanding securities of New Asia Holdings Inc.</li>
<li>Shares of Vision Marine Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VMAR#NASDAQ">VMAR</a>)got a boost, surging 58% to $2.21 after the company announced it filed its latest patent application with the United States Patent and Trademark Office for a Battery Authentication Encryption Technology.</li>
<li>Moving iMage Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MITQ#NYSE">MITQ</a>) shares were also up, gaining 68% to $1.21.</li>
</ul>
Equities Trading DOWN
<ul>
<li>Meiwu Technology Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WNW#NASDAQ">WNW</a>) shares dropped 63% to $0.35.</li>
<li>Shares of Aclarion, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) were down 62% to $0.0367 after the company reported the pricing of $14.4m public offering of common stock and warrants.</li>
<li>Azitra, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZTR#NYSE">AZTR</a>) was down, falling 40% to $0.2530 after the company announced the pricing of a $1.5 million public offering.</li>
</ul>
Commodities In commodity news, oil traded up 1.2% to $78.41 while gold traded up 0.8% at $2,702.50.
Silver traded up 2% to $30.970 on Wednesday, while copper rose 0.7% to $4.3735.
Euro zone
European shares were higher today. The eurozone's STOXX 600 surged 1.2%, Germany's DAX 40 gained 1.6% and France's CAC 40 gained 1%. Spain's IBEX 35 Index gained 1.2%, while London's FTSE 100 gained 0.9%.
Asia Pacific Markets
Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 falling 0.08%, China's Shanghai Composite Index declining 0.43%, Hong Kong's Hang Seng Index gaining 0.34% and India's BSE Sensex rising 0.29%.
Economics
The headline Consumer Price Index rose 2.9% year-over-year in December, according to Wednesday's data from the Bureau of Labor Statistics.
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/25/01/42997542/top-3-tech-and-telecom-stocks-that-may-explode-this-quarter">Top 3 Tech And Telecom Stocks That May Explode This Quarter</a></li>
</ul>

Earnings

Equities

Eurozone

Commodities

Intraday Update

Markets

Trading Ideas

ACON

AZTR

MITQ

SGBX

VMAR

Dow Jumps 600 Points; US Inflation Increases To 2.9% In December

Scotiabank analyst Ovais Habib maintains Centerra Gold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CGAU#NYSE">CGAU</a>) with a Sector Outperform and lowers the price target from $10 to $9.

CGAU

Scotiabank Maintains Sector Outperform on Centerra Gold, Lowers Price Target to $9

XXII

22nd Century Group shares are trading higher after the FDA announced it proposed significant step towards reducing nicotine to minimally or nonaddictive level in cigarettes and other combusted tobacco products.

One question that consistently comes across my desk is why we maintain a global value portfolio when growth stocks and U.S. markets are clearly dominating the investment landscape. The answer, quite frankly, is that&#8217;s exactly why we&#8217;re doing it.
The United States has maintained its position as the world&#8217;s dominant economy and market for some time, but this dominance has intensified significantly in the aftermath of the COVID pandemic. Our leadership in implementing relief funds, stimulus programs, interest rate management to combat inflation, and supply chain repairs has been unmatched. Add to this our current supremacy in artificial intelligence development (at least among public companies), and it&#8217;s no surprise that U.S. markets now represent about 70% of global market capitalization.
However, this dominance comes at a price. U.S. stocks are trading at significantly higher multiples of earnings, asset values, and dividends compared to many international markets, where valuations are often half of what we&#8217;re seeing domestically. While these markets may be out of favor, history has consistently shown that the most successful investors are those willing to venture where others fear to tread.
The Value of Contrarian Investing Looking back at market history, some of the most profitable opportunities have emerged from moments of market distress. Consider the crash of 1987 &#8211; investors who had the courage to buy during or shortly after the crash reaped substantial gains. Similar opportunities presented themselves during the S&amp;L crisis with healthy banks, in the aftermath of the junk bond implosion following Drexel Burnham&#8217;s collapse, and during the tech sector&#8217;s meltdown in 2002-2003.
Yes, there&#8217;s always the possibility that buying into dire situations could result in massive losses if the world truly implodes. But at that point, your stock portfolio&#8217;s performance would likely be the least of your concerns.
Current Global Market Dynamics Europe currently presents what many view as a challenging investment landscape. The Japanese political and economic situation continues to perplex observers, particularly given their substantial debt-to-GDP ratio. However, Japan continues to not just survive but thrive, and we&#8217;re witnessing unprecedented success in corporate activism campaigns across Asia, particularly in Japan, where efforts to unlock shareholder value are gaining traction.
This global approach isn&#8217;t new. John Templeton pioneered this strategy, famously launching his career by borrowing $10,000 to purchase a portfolio of NYSE-listed stocks trading under $1. While some went bankrupt, the portfolio quadrupled over several years, marking the beginning of his illustrious career. Templeton went on to become a trailblazer in global value investing, achieving impressive compounded returns over a long career.
The Perfect Stock Portfolio&#8217;s Global Perspective Our portfolio&#8217;s international approach has proven highly profitable over the years. We&#8217;ve successfully invested in Russian steel companies, banks, and mining operations, South African diamond mines, Indian conglomerates, European banks, and British bakeries. By maintaining a global perspective while adhering to our core criteria &#8211; reasonable valuations, dividend payments, and conservative finances &#8211; we&#8217;ve significantly enhanced our returns.
Currently, finding stocks in the U.S. that trade below asset value, maintain strong balance sheets with minimal debt, offer reasonable yields, and remain profitable is increasingly challenging. In contrast, Europe and Japan present numerous opportunities meeting these criteria. We&#8217;ve even identified select Chinese companies that qualify under our stringent standards.
Regional Market Analysis The Chinese market remains a significant concern for global investors. Growth projections indicate a slowdown to 4.5% in 2025 from nearly 5% last year, with further deceleration expected in 2026. This situation could worsen if Donald Trump implements his proposed tariffs. However, Xi Jinping&#8217;s government is discussing various stimulus measures, including property market support, increased debt issuance, and potential interest rate and reserve requirement adjustments by the People&#8217;s Bank of China. European markets present an interesting value proposition despite lagging U.S. growth. Unlike the U.S., European markets are heavily weighted toward financials, energy, and industrials rather than tech giants (with notable exceptions like ASML). While their renewable energy initiatives haven&#8217;t fully delivered, the sector maintains growth potential. European markets currently trade at roughly half the valuation levels of U.S. stocks while offering higher dividend yields.
Japan's market dynamics remain complex but promising. Despite challenges including high government debt and an aging population, they&#8217;ve maintained stability. Recent developments include potential rate hikes amid inflationary pressures and wage growth. The government&#8217;s $250 billion stimulus package, focusing on digital innovation and energy cost subsidies, has received positive market response. Many analysts anticipate the Nikkei 225 reaching new all-time highs this year.
New Portfolio Addition: Peabody Energy Corporation (Ticker: BTU) Despite our international focus, our latest addition is a U.S.-based company in perhaps the most unloved sector globally &#8211; coal. Peabody Energy Corporation, headquartered in St. Louis, operates globally, serving customers in 25 countries with both thermal and metallurgical coal.
Their recent $3.8 billion acquisition of Anglo-American&#8217;s Australian steelmaking coal assets is transformative, potentially tripling their metallurgical coal production by 2026. While developed markets are transitioning away from thermal coal, demand remains strong in emerging markets, particularly China and India. Additionally, coal still generates approximately 20% of U.S. electricity.
Peabody&#8217;s fundamentals are compelling:
<ul>
<li>Annual revenue exceeding $1 billion</li>
<li>Substantial free cash flow</li>
<li>Strong liquidity</li>
<li>Manageable debt levels</li>
<li>1.63% dividend yield</li>
<li>Trading at approximately 5x earnings</li>
<li>75% of tangible book value</li>
</ul>
While the coal industry faces regulatory and environmental headwinds in Western markets, global demand persists, particularly in emerging economies. The Perfect Stock Portfolio continues to focus on dividend collection and deeply undervalued stocks, maintaining our strategy of beating the markets through patient, value-oriented investing.

Opinion

The Case for Global Value Investing: January 2025 Perfect Stocks Report

Intel Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTC#NASDAQ">INTC</a>) <a href="https://www.benzinga.com/topic/intel" target="_blank" rel="noreferrer noopener">announced Tuesday its intention</a> to separate Intel Capital, its global venture capital arm, into a standalone fund.
The new fund will enable greater autonomy and the flexibility to <a target="_blank" href="https://www.businesswire.com/news/home/20250114487691/en/Intel-Capital-to-Become-Standalone-Investment-Fund" rel="noreferrer noopener">attract external capital</a>.
Intel will remain an anchor investor in the new company.
Also Read: <a href="https://www.benzinga.com/25/01/42983278/google-stock-boosted-by-ai-growth-cloud-expansion-and-cost-discipline-despite-doj-and-generative-ai-challenges-analyst" target="_blank" rel="noreferrer noopener">Google Stock Boosted By AI Growth, Cloud Expansion, Cost Discipline Despite DOJ And Generative AI Challenges: Analyst</a>
Established in 1991, Intel Capital is a leading corporate venture investor with over $5 billion in assets under management.
Standalone operations will likely begin in the second half of 2025 when Intel Capital will operate under a new name.
The existing Intel Capital team will move to the new company, and business operations will continue throughout the transition.
In December, Bloomberg highlighted CFO Dave Zinsner, who did not rule out the possibility of selling the company's <a href="https://www.benzinga.com/media/24/12/42482813/intel-cfo-hints-at-possible-division-split-as-company-struggles-to-recapture-moat" target="_blank" rel="noreferrer noopener">factory and product-development divisions</a>.
Zinsner took over the position of Intel's interim co-CEO along with&nbsp;Michelle Johnston Holthaus following Pat Gelsinger's exit.
Intel&nbsp;stock plunged over 59% in the last 12 months as it failed to capitalize on the shift to artificial intelligence technology akin to the likes of Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>). Nor Intel succeeded in turning around its AI accelerator chip business with the Gaudi chip akin to the likes of Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Intel restructured several smaller divisions under Gelsinger in the past two years and reduced its workforce in 2024.
Intel is <a target="_blank" href="https://www.benzinga.com/markets/equities/24/10/41395473/intel-reportedly-considers-selling-minority-stake-in-altera-unit-for-17b-amid-market-challenges-" rel="noreferrer noopener">spinning off-chip division</a> Altera with plans to become a publicly traded company, CNBC <a target="_blank" href="https://www.cnbc.com/2025/01/14/intel-to-spin-off-venture-capital-arm-can-raise-outside-money.html" rel="noreferrer noopener">reports</a>. It also owns the largest&nbsp;<a target="_blank" href="https://www.benzinga.com/m-a/24/09/41069587/whats-going-on-with-intel-stock-on-friday" rel="noreferrer noopener">Israeli autonomous driving company</a>, Mobileye Global Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>). In 2024, Intel tried to turn its foundry business into an independent unit.
Investors can gain exposure to Intel through Vanguard S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>).
Price Action: Intel stock is up 0.10% to $19.22 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/25/01/42983710/ibm-globant-epam-top-it-bets-for-2025-driven-by-demand-trends-and-margin-expansion-analyst" target="_blank" rel="noreferrer noopener">IBM, Globant, EPAM Top IT Bets For 2025, Driven by Demand Trends And Margin Expansion: Analyst</a></li>
</ul>
Image: Shutterstock

Tech

Media

INTC

MBLY

NVDA

Intel Plans To Spin Off $5 Billion Venture Capital Segment, Will Remain Anchor Investor

Moving iMage Technologies Shares Resume Trade

RBC Capital analyst Sean Dodge reiterates Icon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLR#NASDAQ">ICLR</a>) with a Outperform and maintains $263 price target.

ICLR

RBC Capital Reiterates Outperform on Icon, Maintains $263 Price Target

MASS

908 Devices shares are trading higher after the company reported preliminary Q4 revenues above estimates.

JX Luxventure Shares Resume Trade

Azitra shares are trading lower after the company announced the pricing of a $1.5 million public offering.

Guidance

IPOs

Goldman Sachs CFO Says We Are Optimistic On The Outlook For 2025, Expect Further Pick Up In M&A And IPO Activity

Scotiabank analyst Ovais Habib maintains First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Sector Perform and lowers the price target from $6.5 to $6.

Scotiabank Maintains Sector Perform on First Majestic Silver, Lowers Price Target to $6

Moving iMage Technologies Shares Halted On Circuit Breaker To The Downside, Stock Now Up 68%

GIFT

Giftify shares are trading higher after the company announced the pricing of a $600,000 public offering of 600,000 shares of its common stocks with no warrants at $1.00 per share.

Macro Economic Events

Economics

Federal Reserve

Goldman Sachs CEO Says The Fed's Current Stress Testing Creates Uncertainty

RBC Capital analyst Sean Dodge maintains Health Catalyst (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCAT#NASDAQ">HCAT</a>) with a Sector Perform and lowers the price target from $9 to $7.

HCAT

RBC Capital Maintains Sector Perform on Health Catalyst, Lowers Price Target to $7

BECN

Beacon Roofing Supply shares are trading higher after QXO announced a proposal to acquire the company for $124.25 per share in cash for a total valuation of approximately $11 billion.

Bullfrog AI announces pricing of offering and private placement for proceeds of $3.13M

BullFrog AI (BFRG) Holdings announced that it has closed its previously announced definitive agreement for the purchase and sale of an aggregate of...

Bullfrog AI announces closing of registered direct offering, private placement

BullFrog AI (BFRG), announced its VP Artificial Intelligence, Enrique Garcia-Rivera, Ph.D., will present at Google's inaugural Cancer AI Symposium ...

Bullfrog AI to present at Google's Cancer AI Symposium

Bullfrog AI Holdings files secondary offering of common stock underlying warrants

Issuable upon exercise of common stock purchase warrants. Also files to sell 62.6M shares of common stock for holders underlying placement agent wa...

Bullfrog AI files to sell 1.565M shares of common stock for holders

BullFrog AI (BFRG) Holdings announced the appointment of Josh Blacher as its Chief Financial Officer, effective immediately. This appointment comes...

Bullfrog AI names Josh Blacher CFO

BullFrog AI names Josh Blacher as its CFO

The latest announcement is out from BullFrog AI Holdings, Inc. ( ($BFRG) ). BullFrog AI Holdings, Inc. has appointed Josh Blacher as the new Chief ...

BullFrog AI Names Josh Blacher as New CFO

BullFrog AI (BFRG) Holdings issued a letter to stockholders from its CEO Vin Singh, which read in part, "In thinking back on this past year, it is ...

Bullfrog AI CEO: 2025 focus will remain on AI-driven solution commercialization

BullFrog AI (BFRG) announced its participation in the TechBio track at Biotech Showcase and RESI JPM, both taking place during the annual JP Morgan...

Bullfrog AI to present at Biotech Showcase and RESI JPM

BFRG

Health Care

Press Releases

General

BullFrog AI Announces Publication of Data Supporting Potential of Liver Disease Treatment Candidate BF-114

Management

BullFrog AI Strengthens Scientific Advisory Board with the Addition of GSK Veteran and Industry Pioneer Dr. John Baldoni

Bullfrog AI Announces Pricing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Offerings

WallachBeth Capital Announce Pricing of Bullfrog AI's Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

Bullfrog AI Announces Closing of Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

WallachBeth Capital Announces Closing of Bullfrog AI Registered Direct Offering and Concurrent Private Placement for Aggregate Gross Proceeds of $3.13 Million

BullFrog AI's VP Artificial Intelligence to Present at Google's Cancer AI Symposium

Comments

Bullfrog AI Hldgs

Bullfrog AI Hldgs (BFRG) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL